Skip to content

Ansella Therapeutics

Country not established

Devices
1

What Ansella Therapeutics makes

Ansella Therapeutics manufactures the Cerynë Intimate Care product line, which includes medical-grade incontinence pads and protective undergarments designed for adult pelvic health management.

The company’s portfolio is regulated under FDA Class II devices and is listed via 510(k) clearance. Ansella Therapeutics is based in the United States.

AI-generated from registry data, 2 Oct 2026. Not verified by deviCERTS or the manufacturer.

Catalogue1

Newest first, rows 1-1 of 1

  • Cerynë Intimate Care Ref K250488

    Active Regimes: 510(k) Registry: 510(k) Class:II

Frequently asked questions

How many devices does Ansella Therapeutics have in the registry?

The registry currently lists 1 device for Ansella Therapeutics. Devices recorded under merged duplicate company entries are counted once.

Which registries list Ansella Therapeutics's devices?

Among its 1 most recently registered device, Ansella Therapeutics has devices listed in FDA 510(k) (1 device).

What risk classes do Ansella Therapeutics's devices fall under?

Among its 1 most recently registered device, the classes recorded for Ansella Therapeutics's devices are Class II. Each device page shows its own class and authorisation.

What are the newest devices from Ansella Therapeutics in the registry?

The most recently registered devices listed for Ansella Therapeutics include Cerynë Intimate Care.

Generated automatically from registry data and not verified by a human reviewer.